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1 The wide distribution of the uridine nucleotide-activated P2Y2, P2Y4 and P2Y6 receptors
suggests a role for UTP as an important extracellular signalling molecule. However, direct evidence
for UTP release and extracellular accumulation has been addressed only recently due to the lack of a
sensitive assay for UTP mass. In the present study, we describe a method that is based on the
uridinylation of [14C]-glucose-1P by the enzyme UDP-glucose pyrophosphorylase which allows
quanti®cation of UTP in the sub-nanomolar concentration range.
2 The UTP-dependent conversion of [14C]-glucose-1P to [14C]-UDP-glucose was made irreversible
by including the pyrophosphate scavenger inorganic pyrophosphatase in the reaction medium and
[14C]-glucose-1P and [14C]-UDP-glucose were separated and quanti®ed by HPLC. Formation of
[14C]-UDP-glucose was linearly observed between 1 and 300 nM UTP. The reaction was highly
speci®c for UTP and was unaected by a 1000 fold molar excess of ATP over UTP.
3 Release of UTP was measured with a variety of cells including platelets and leukocytes, primary
airway epithelial cells, rat astrocytes and several cell lines. In most resting attached cultures,
extracellular UTP concentrations were found in the low nanomolar range (1 ± 10 nM in 0.5 ml
medium bathing 2.5 cm2 dish). Up to a 20 fold increase in extracellular UTP levels was observed in
cells subjected to a medium change. Extracellular UTP levels were 10 ± 30% of the ATP levels in
both resting and mechanically-stimulated cultured cells. In unstirred platelets, a 1 : 100 ratio UTP/
ATP was observed. Extracellular UTP and ATP increased 10 fold in thrombin-stimulated platelets.
4 Detection of UTP in nanomolar concentrations in the medium bathing resting cultures suggests
that constitutive release of UTP may provide a mechanism of regulation of the basal activity of
uridine nucleotide sensitive receptors.
Keywords: Extracellular nucleotides; UTP release; P2Y receptors; UTP measurement
Abbreviations: UDPG, uridine diphosphoglucose; HPLC, high performance liquid chromatography; DMEM, Dulbecco's
modi®ed Eagle's medium; HNE, human nasal epithelial cells; PMNs, polymorphonuclear leukocytes
Introduction
The physiological signi®cance of ATP and ADP as extra-
cellular signalling molecules is well established (Burnstock,
1972; Gordon, 1986; Dubyak & El-Moatassim, 1993). Both
molecules are released in a regulated manner from excitatory
and non-excitatory cells, and these released nucleotides
interact with both the P2X receptor subfamily of ligand-gated
ion channel receptors and the P2Y receptor subfamily of G
protein-coupled receptors (Burnstock & Kennedy, 1985;
Abbracchio et al., 1996; Fredholm et al., 1997).
The physiological role of extracellular uridine nucleotides is
less well understood. However, extracellular UTP and UDP
promote widespread and pronounced cellular responses, and
three of the ®ve cloned human P2Y receptors are potently
activated by uridine nucleotides. The P2Y2 receptor is activated
equipotently by UTP and ATP (Lustig et al., 1993; Parr et al.,
1994), the P2Y4 receptor is speci®cally activated byUTP (Cohen
et al., 1990; Nguyen et al., 1995; Nicholas et al., 1996), and the
P2Y6 receptor is speci®cally activated by UDP (Chang et al.,
1995; Nicholas et al., 1996). Support for the physiological
importance of extracellular uridine nucleotides would be
provided by direct demonstration of the regulated release of
UTP from a range of tissues. However, measurement of
intracellular as well as extracellular UTP levels has been dicult
due to the lack of a sensitive assay for the quanti®cation of UTP
mass at physiological or pharmacological levels (Anderson &
Parkinson, 1997). Recently, we have developed an enzymatic
approach for quanti®cation ofUTPbased on the high selectivity
of UDP-glucose pyrophosphorylase for UTP as a co-substrate
for the conversion of glucose-1P toUDP-glucose (Lazarowski et
al., 1997a). By utilizing [14C]-glucose-1P as a tracer substrate, the
UTP-dependent formation of [14C]-UDP-glucosewas quanti®ed
byHPLCand utilized to establish the occurrence ofUTP release
from 1321N1 human astrocytoma cells following mechanical
stimulation (Lazarowski et al., 1997a). In the present study, we
describe in detail the methodology that allows accurate
quanti®cation of UTP in the subnanomolar concentration
range, and we establish conditions that illustrate the potential
of measuring UTP at sub-picomolar levels. In addition, the
intracellular and extracellular concentrations of UTP have been
determined with a variety of cells, and our results suggest that
both constitutive and regulated release of UTP may occur from
many dierent cell types.
Methods
Cell culture
1321N1 Human astrocytoma cells and C6 rat glioma cells were
grown on 24-well plastic plates (Costar) in the presence of high*Author for correspondence; E-mail: edu@med.unc.edu
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glucose Dulbecco's Modi®ed Eagles Medium (DMEM-H)
supplemented with 5% foetal bovine serum (FBS) and
antibiotics as described previously (Lazarowski & Harden,
1994; Lazarowski et al., 1997a). Human bronchial epithelial
(16HBE14o7) cells were grown on vitrogen coated plates as
non-polarized epithelium in the presence of DMEM-H plus
10%FBS. Cystic ®brosis (CF) tracheal epithelial (CF/T43) cells
were grown on 24-well plastic plates in keratinocyte growth
medium (Brown et al., 1991). Primary human nasal epithelial
cells (HNE) and T-84 human colonic epithelial cells were grown
as a polarized epithelium on 12-mm transwells (costar) as
described previously (Watt et al., 1998). PC12 rat pheochro-
mocytoma cells were grown on collagen coated 24-well plastic
plates in 85% DMEM-H, 10% FBS and 5% heat inactivated
horse serum. During the last 5 ± 7 days of culture, PC12 cells
were dierentiated with 100 ng ml71 nerve growth factor
(Upstate Biotechnology, NY, U.S.A.) in 94% DMEM-H, 1%
inactivated horse serum and 5% FBS. Con¯uent cultures of
primary rat astrocytes and nerve cells grown on 12-well plastic
plates were generously provided by Dr Ken McCarthy. For the
experimental designs, the cells were washed (i.e., the culture
medium was aspirated and the dishes immediately rinsed gently
twice with 0.5 ml of pre-warmed phenol red-free DMEM-H
medium) and incubated in 0.5 ml of fresh DMEM-H medium.
Medium samples were collected either immediately after the cell
wash (medium change) or after a 4 h incubation period under
undisturbed conditions (steady state). The collected medium
was rapidly centrifuged (4006g, 2 min) to remove potentially
detached cells and the resulting supernatant was boiled for
1 min. Aliquots of 400 and 50 ml were used for UTP and ATP
measurements, respectively. For experiments with polarized
HNE and T-84 cells, only the mucosal medium was processed.
Isolation of human platelets and neutrophils
Platelets were isolated from blood of healthy donors who had
not taken medication for at least 2 weeks. Blood (60 ml)
containing 3.8% trisodium citrate was centrifuged at 2006g for
20 min. The platelet-rich plasma was then centrifuged for
15 min at 8006g. Contaminant red blood cells were depleted by
rapid centrifugation in a microcentrifuge (2610 s at
15,000 r.p.m.). Platelets were washed twice with 10 ml
DMEM-H and resuspended in phenol red-free DMEM-H at a
concentration of 1.256108 cells ml71. Polymorphonuclear
neutrophils (PMNs) were isolated from blood of healthy
volunteers and kindly provided for this study by Dr Margrith
Verghese (Verghese et al., 1996). PMNs were suspended in
phenol red-free DMEM-H at a ®nal concentration of 107
cells ml71.
Quanti®cation of UTP mass
UTP concentrations were determined using a UDP-glucose
pyrophosphorylase-catalyzed reaction. Except where indicated
otherwise, incubations were for 60 min in 0.5 ml phenol red-
free DMEM/HEPES (pH 8.0) containing 0.5 units ml71
UDP-glucose pyrophosphorylase, 0.5 units ml71 inorganic
pyrophosphatase, and 1 mM 0.15 mCi [14C]-glucose-1P. Reac-
tions were terminated by boiling the samples for 1 min. The
per cent conversion of [14C]-glucose-1P to [14C]-UDP-glucose
was determined by HPLC.
HPLC analysis
Glucose-1P, UDP-glucose, and UTP were separated by HPLC
(Shimadzu) via a 60-AÊ Dynamax C18 column (Varian, CA,
U.S.A.) with the mobile phases consisting of KH2PO4 17 mM,
tetrabutylethylhydrogen sulphate (TBEHS), pH 5.3 8 mM
(Buer A), and 10% methanol in KH2PO4 100 mM, TBEHS,
pH 5.3 8 mM (Buer B). The system developed isocratically in
100% buer A for 10 min and was subsequently shifted to
100% buer B for an additional 15 min. Absorbance at
264 nm was monitored with a SPD-10A UV detector
(Shimadzu), and radioactivity was determined on-line with a
Flo-One Radiomatic beta detector (Packard, Canberra,
Australia) as described previously (Lazarowski et al., 1997a).
Measurement of ATP by the luciferin-luciferase assay
Samples (50 ml aliquots) were diluted 1 : 6 with water. A
46luciferin-luciferase cocktail (300 mM luciferin, 5 mg ml71
luciferase, HEPES (pH 7.8) 25 mM, MgCl2 6.25 mM, EDTA
0.63 mM, 75 mM dithiotritiol, 1 mg ml71 bovine serum
albumin) was added to the diluted samples via a LB953
AutoLumat luminometer (Berthold GmbH, Germany). Sam-
ple luminescence was compared to an ATP standard curve
performed for each individual experiment as previously
described (Watt et al., 1998).
Reagents
All nucleoside triphosphates were purchased from Pharmacia
(Uppsala, Sweden). UDP-glucose pyrophosphorylase was
from Boehringer Mannheim (Indianapolis, IN, U.S.A.).
Luciferin, luciferase, inorganic pyrophosphatase, UDP-
glucose, glucose-1P, and TBEHS were from Sigma (St.
Louis, MO, U.S.A.). [14C]-glucose-1P (330 mCi mmol71),
[3H]-UTP (50 Ci mmol71), and [a33P]-UTP (3000 Ci
mmol71) were from Amersham (Arlington Heights, IL,
U.S.A.).
Results
Lack of availability of reliable methodology for measuring
UTP concentrations at low levels in biological tissues
prompted us to develop a coupled enzymatic method for
quantitation of UTP mass. This assay is based on the
selectivity for UTP of the enzyme UDP-glucose pyrophos-
phorylase which converts UTP and glucose-1P into UDP-
glucose in the obligatory step that precedes the incorporation
of glucose into glycogen (Leloir, 1971): UTP+glucose-
1P.UDP-glucose+PPi.
Although the equilibrium constant of the reaction is 0.29 ±
0.34 in the forward direction (Hansen et al., 1996), it can be
forced quantitatively in the direction of UDP-glucose synthesis
by including inorganic pyrophosphatase as an enzymatic
scavenger of pyrophosphate: UTP+glucose-1P.UDP-
glucose+PPi?UDP-glucose+2Pi.
The ®delity of the two enzymatic steps was ®rst established
using [3H]-UTP as a substrate. [3H]-UTP (100 nM) was
recovered unchanged following a 1 h incubation with UDP-
glucose pyrophosphorylase and inorganic pyrophosphatase in
the absence of glucose-1P (Figure 1a). In contrast, approxi-
mately 50% of [3H]-UTP was converted to [3H]-UDP-glucose
by UDP-glucose pyrophosphorylase in the presence of 1 mM
glucose-1P during the same period (Figure 1b). Inclusion of
inorganic pyrophosphatase resulted in near 100% conversion
of [3H]-UTP to [3H]-UDP-glucose (Figure 1c). Formation of
[3H]-UDP-glucose from [3H]-UTP was equally ecient in the
presence of a 1000 fold excess of ATP, GTP or CTP (not
shown), indicating that these nucleotides do not compete with
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UTP for the UDP-glucose pyrophosphorylase-catalyzed
reaction. The substrate speci®city of UDP-glucose pyropho-
sphorylase was further investigated in experiments in which
[14C]-glucose-1P (1 mM) was incubated with UTP or ATP
(Figure 2). [14C]-glucose-1P remained unchanged in the
absence of UTP (Figure 2a). In contrast, formation of [14C]-
UDP-glucose was readily observed in the presence of 100 nM
UTP (Figure 2b). Figure 2c shows that no formation of [14C]-
ADP-glucose occurred in the presence of 100 mM ATP (the
elution time of ADP-glucose (ADPG) is indicated by an arrow
on top of Figure 2a). These results are consistent with the
reported substrate speci®city of UDP-glucose pyrophosphor-
ylase which does not utilize ATP as a substrate (Hansen et al.,
1996).
The time course of the UDP-glucose pyrophosphorylase-
catalyzed reaction was determined in the presence of 1 mM
glucose-1P and 100 nM UTP. Approximately 5% of the [14C]-
glucose-1P was converted to [14C]-UDP-glucose after 1 h
under the conditions detailed in Figure 3a, indicating that
approximately 50% of the initial UTP was utilized in the
reaction. Moreover, inclusion of 0.5 units ml71 inorganic
pyrophosphatase resulted in near full conversion of substrate
to product within 40 min of incubation (Figure 3a).
Conversion of [14C]-glucose-1P to [14C]-UDP-glucose was
linearly dependent on the concentration of UDP-glucose
pyrophosphorylase (Figure 3b) over a range from 5 ± 50 mg
enzyme ml71 (0.1 ± 1 units ml71). The reaction exhibited a pH
optimum of pH 8.0 (Figure 3c).
Since our goal was to optimize conditions to quantify
UTP at physiological levels, we further examined the
eciency of the conversion of UTP to UDP-glucose utilizing
nanomolar and subnanomolar concentrations of UTP. In
the presence of 1 mM glucose-1P, over 80% conversion of
[a33P]-UTP to [33P]-UDP-glucose occurred at all concentra-
tions (0.1 ± 100 nM) of UTP (Figure 4a). Thus, UTP could
be quantitated at concentrations that are several orders of
magnitude below its Km for the UDP-glucose pyrophos-
phorylase-catalyzed reaction (Km UTP=563 mM, Km
glucose-1P=172 mM, Duggleby et al., 1996). The rate of the
reaction was dramatically accelerated with 1 mM glucose-1P
(100% conversion in 1 min; Figure 4b). However, the
sensitivity of the assay ultimately is limited by the poor
eciency of conversion observed at concentrations less than
1 mM glucose-1P (Figure 4b). The relatively low speci®c
activity of commercially available radioactive glucose-1P
([14C]-UDP-glucose, SA *300 mCi mmol71) also limits the
total amount of radioactive substrate to 50.3 mCi ml71.
Figure 1 Glucose-1P-dependent conversion of [3H]-UTP to [3H]-
UDP-glucose. Eect of inorganic pyrophosphatase. HPLC tracings
showing the conversion of 100 nM 0.5 mCi [3H]-UTP to [3H]-UDP-
glucose. (a) [3H]-UTP remained intact after a 1 h incubation with
0.5 units ml71 UDP-glucose pyrophosphorylase and inorganic pyr-
ophosphatase in the absence of glucose-1P. (b) In the presence of
1 mM glucose-1P, approximately 50% of the initial [3H]-UTP was
converted to [3H]-UDP-glucose (UDPG) by 0.5 units ml71 UDP-
glucose pyrophosphorylase after 1 h. (c) Inclusion of inorganic
pyrophosphatase resulted in near full conversion of [3H]-UTP to
[3H]-UDP-glucose during the same incubation period. The data are
representative of six experiments performed in duplicate.
Figure 2 UTP-dependent UDP-glucose pyrophosphorylase-cata-
lyzed conversion of [14C]-glucose-1P to [14C]-UDP-glucose. HPLC
tracings corresponding to 1 h incubations in the presence of
0.5 units ml71 of both UDP-glucose pyrophosphorylase and inor-
ganic pyrophosphatase, 1 mM [14C]-glucose-1P and either vehicle (a),
100 nM UTP (b) or 100 mM ATP (c). The data are representative of at
least three experiments performed with duplicate samples. The elution
time of glucose-1P (Gluc-1P), UDP-glucose (UDPG), and ADP-
glucose (ADPG) are indicated with arrows on top of a.
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Thus, the assay developed here utilizing 1 mM [14C]-glucose-
1P (*200,000 c.p.m. per assay) exhibits a threshold
sensitivity of *1 nM UTP (Figure 5a, left). That is, in the
presence of 1 nM UTP in a 0.5 ml reaction volume, the
predicted accumulation of approximately 200 c.p.m. [14C]-
UDP-glucose (0.1% of the total counts) can be reliably
detected over baseline (Figure 5a, left).
One approach that would increase the sensitivity of this
assay for UTP would include the use of glucose-1P with higher
speci®c radioactivity, e.g., [32P]-glucose-1P or [33P]-glucose-1P.
Since these compounds are not yet available, we examined the
eectiveness of the conversion of UTP to UDP-glucose
utilizing [a33P]-UTP at picomolar concentrations in the
presence of 1 mM glucose-1P. Quantitative conversion of
[33P]-UTP to [33P]-UDP-glucose occurred in a 1 h incubation
with UTP at concentrations as low as 20 pM (Figure 5b, left).
Thus, the UDP-glucose pyrophosphorylase catalyzed-reaction
as described here exhibits a linear dependence on UTP
concentration of near ®ve orders of magnitude (20 pM UTP
to 0.3 mM UTP).
In recent studies with a human astrocytoma cell line, we
have observed release of UTP in pharmacologically important
concentrations from mechanically-stimulated cells (Lazarows-
ki et al., 1997a). As a ®rst step in determining whether UTP
release re¯ects a more general phenomenon, we have measured
the UTP content and extracellular levels of UTP in other
tissues. The concentration of UTP in each sample was
compared with ATP concentration measured by the luciferin-
luciferase assay (Table 1).
The intracellular amount of UTP ranged between 500
and 8000 pmol per million cells in the dierent cells
studied. The cellular concentration of UTP was 10 ± 30%
of that determined for ATP. Extracellular UTP was
present in detectable amounts for many cells under resting
conditions, but extracellular UTP was not detected (i.e.,
51 nM) with non-stimulated C6 glioma cells, T84 cells,
primary nerve cells and astrocytes. However, enhanced
accumulation of extracellular UTP was observed after
mechanical stimulation of the cells by a change of
medium. As we previously observed with 1321N1 human
astrocytoma cells, the ratio of extracellular UTP to ATP
typically was in the range of 1 : 3 to 1 : 10 for most cells
studied. The extracellular concentration of UTP was the
highest with neutrophils and platelets in suspension (Table
1) probably re¯ecting cell stress and activation or damage
during isolation procedures. Notably, stimulation of
platelets with thrombin (2 units ml71) caused a 10 fold
increase in accumulation of extracellular UTP and ATP.
Unlike most cells, where extracellular nucleotide ratios
re¯ected the cellular content, a ratio *1 : 100 of
Figure 3 UDP-glucose pyrophosphorylase-catalyzed conversion of
[14C]-glucose-1P to [14C]-UDP-glucose. (a) Incubations were for the
indicated times in the presence of 1 mM [14C]-glucose-1P, 100 nM UTP
and 0.5 units ml71 UDP-glucose pyrophosphorylase with or without
the addition of 0.5 units ml71 inorganic pyrophosphatase (Inorganic
PPi-ase). (b) The eect of increased concentrations of UDP-glucose
pyrophosphorylase was determined after a 15 min incubation period
in the presence of 0.5 units ml71 inorganic pyrophosphatase, 1 mM
[14C]-glucose-1P and 100 nM UTP. (c) The pH dependence was
examined in the presence of 0.5 units ml71 of UDP-glucose pyropho-
sphorylase and inorganic pyrophosphatase. The data represent the
mean value (+s.e.mean) from three experiments performed with
duplicate samples.
Figure 4 Eect of substrate concentration on the conversion of
[a33P]-UTP to [33P]-UDP-glucose. Incubations were in the presence of
0.1 mCi [a33P]-UTP, 0.5 units ml71 UDP-glucose pyrophosphorylase
and inorganic pyrophosphatase and (a) 1 mM glucose-1P (Gluc-1P)
and the indicated concentration of UTP and (b) 100 nM UTP and the
indicated concentration of glucose-1P. The data represent the mean
value from at least three experiments performed with duplicate
samples (in a, error bars were omitted for clarity).
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extracellular UTP to ATP was observed with platelets
while the total intracellular UTP :ATP ratio was 1 : 25
(Table 1).
Discussion
The assay for UTP described here provides reliable detection
of UTP for the ®rst time in biological samples such as cell
supernatants and cell lysates. The sensitivity of this coupled
enzymatic assay using [14C]-glucose as a radiolabelled co-
substrate is at least two orders of magnitude greater than other
methods previously available (Keppler et al., 1970 ; Sasvari-
Szekely et al., 1975). Moreover, we show here using
radiolabelled UTP in proof of principle experiments that the
assay is linear to at least the low picomolar range of
concentrations of UTP. Therefore, use of [33P]-glucose-1P or
[32P]-glucose-1P as a substrate will provide an assay of UTP
mass to concentrations much lower than our results indicate
exist under resting levels in the extracellular medium of a
variety of cell preparations. As predicted from the previously
established selectivity of UDP-glucose pyrophosphorylase for
UTP, concentrations of ATP and other nucleoside tripho-
sphates that exceeded the concentration of UTP by three
orders of magnitude do not interfere with the quantitation of
UTP using this assay. Further, no evidence of other interfering
molecules in tissues could be ascertained from experiments in
which UTP was added as an internal standard to extracts from
various cell culture supernatants (data not shown). Thus, we
describe a very sensitive and speci®c assay that should ®nd
usefulness in accurate quantitation of UTP mass under a
variety of experimental conditions.
The luciferin/luciferase assay for ATP has provided widely
used methodology for quantitation of ATP mass in biological
tissues at sub-nanomolar concentrations. Thus, ATP has been
known for decades to exist extracellularly and to function both
as an extracellular signalling molecule as well as a source for
extracellular produced adenosine, which in turn activates a
group of G protein-coupled adenosine receptors (Burnstock &
Kennedy, 1985; Gordon, 1986). In contrast, no information on
extracellular UTP has been available until recently. Saiag et al.
(1995) reported that bovine endothelial cells incorporated [3H]-
uridine into UTP, which then was shown to be released by
mechanical stimulation of the cells. We recently reported the
®rst direct quantitation of UTP mass in extracellular medium
Figure 5 The formation of UDP-glucose is linear over a broad
range of UTP concentrations. (a) Conversion of [14C]-glucose-1P to
[14C]-UDP-glucose. (b) Conversion of [a33P]-UTP to [33P]-UDP-
glucose. All incubations were for 1 h in the presence of 1 mM glucose
1-P and 0.5 units ml71 of UDP-glucose pyrophosphorylase and
inorganic pyrophosphatase. The data represent the mean value from
one experiment performed with duplicate samples that diered by less
than 10% from each other. The experiments were repeated at least
three times and similar results were obtained.
Table 1 Measurement of ATP and UTP in various cell types
ATP UTP
Extracellular Intracellular Extracellular Intracellular
Steady state Medium change pmol Steady state Medium change pmol



























































































































Top: ATP and UTP concentrations were determined in the medium (0.5 ml) bathing con¯uent cultures of undisturbed cells (steady
state) or cells that were subjected to a medium change. Bottom: PMNs were suspended at a concentration of 107 ml71 and incubated
for 5 min at 378C without stirring. Platelets (1.256108 ml71) were incubated unstirred for 2 min in the absence or presence of
2 U ml71 thrombin. Extracellular ATP and UTP concentrations (nM) are expressed as the mean value+s.e.mean and as the per cent of
the total ATP and UTP cell content, respectively. The intracellular nucleotide concentrations are expressed as picomoles per million
cells. *Not determined.
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and further illustrated that mechanical stimulation of 1321N1
human astrocytoma cells resulted in co-release of UTP with
ATP (Lazarowski et al., 1997a).
The assay of mass has been extended here to show that
extracellular UTP can be detected in the medium from other
neural as well as non-neural cells including normal and cystic
®brosis airway epithelial cell preparations, and from circulat-
ing leukocytes and platelets. These observations are important
for a number of reasons. For example, the principle Ca2+-
mobilizing receptor on the apical surface of human airway
epithelial cells is a UTP-activated P2Y2 receptor (Mason et al.,
1991; Lazarowski et al., 1997c). Indeed, this receptor has
become an important therapeutic target for treatment of cystic
®brosis and potentially other obstructive airway disease
(Knowles et al., 1991). The availability of an assay for UTP
and the observation of UTP accumulation in the extracellular
medium of airway epithelial cells will provide impetus for
experiments addressing the potential role that extracellular
UTP may play in the physiological regulation of the airway
receptor. Likewise, receptors for ATP and UTP, e.g. the P2Y1
and P2Y2 receptors, are dierentially expressed developmen-
tally in various blood cell lineages (Cliord et al., 1997). The
role of UTP as an extracellular signalling molecule in
in¯ammatory and immunological responses is an important
topic for future investigation. Release of UTP from human
platelets has not been reported previously, although UTP is
thought to be co-stored with ATP in the platelet secretory
granules (Goetz et al., 1971). Our data indicates that thrombin
promotes a 10 fold increase in extracellular UTP levels.
However, the physiological signi®cance of this release remains
to be determined since extracellular concentrations of UTP are
much lower than that of ATP.
The enzyme, UDP-glucose pyrophosphorylase, which was
used for quantitation of UTP levels in this study, also
potentially can be utilized in studies assessing the nucleotide
selectivity of the P2Y receptors. For example, we and others
originally reported that the human P2Y4 receptor is
activated by high concentrations of ATP (Communi et al.,
1995; Nicholas et al., 1996), although no eect of ATP on
this receptor was observed by Nguyen et al. (1995).
Subsequent studies in which the release and accumulation
of UTP and UDP were minimized indicated that ATP is not
an agonist at the human P2Y4 receptor (Lazarowski et al.,
1997a), suggesting that the reported eect of ATP was likely
due to its competitive action on ecto-nucleotidases acting on
endogenous UTP or due to transfer of the terminal
phosphate from ATP to endogenous UDP via nucleoside
diphosphokinase (Lazarowski et al, 1997b). UDP-glucose
pyrophosphorylase should prove useful in addressing
contributions of UTP to biological responses since ATP is
not a substrate for UDP-glucose pyrophosphorylase and this
enzyme eciently and rapidly metabolizes UTP when
glucose-IP is present in millimolar amounts (Figure 4). That
is, UDP-glucose pyrophosphorylase provides a means for
the assessment of the eect of ATP as well as other
nucleotides without any confounding in¯uence of endogen-
ous or contaminant UTP. Similarly, UDP-glucose pyropho-
sphorylase will be useful to assess the true potencies of non-
uridine nucleotides at a pair of recently cloned non-
mammalian P2Y receptors that share relatively high
homology with the human P2Y4 receptor and appear to be
activated by all nucleoside triphosphates (Bogdanov et al.,
1997; Boyer et al., 1997).
The mechanism whereby non-excitatory cells release ATP
(and now UTP) remains unclear. A proposed role for the cystic
®brosis transmembrane regulator CFTR in the release of
nucleotides (Watt et al., 1998) was not substantiated by a
number of studies including experiments with cells from the
CFTR mouse as well as in experiments in which CFTR was
expressed to high levels and ATP mass directly quantitated in
the medium or indirectly measured at the level of the cell
surface by assessing activation of co-expressed P2Y receptors
(Watt et al., 1998). The results described here comparing the
concentration of UTP in the extracellular medium of a variety
of non-secretory cells address neither the mechanism whereby
the extracellular nucleotide appeared nor its intracellular
source. Nonetheless, the similar (but not always identical)
ratio of UTP to ATP in the medium relative to the cell content
suggests the occurrence of a common mechanism and further
suggests that these nucleotides are released by a transport
mechanism that simply re¯ects the relative intracellular
concentrations. It will be important to establish whether other
nucleotides, e.g. CTP, GTP, are released in amounts that
re¯ect their relative intracellular levels. This question takes on
added signi®cance in face of the observation that in contrast to
the UTP speci®city of the human P2Y4 receptor, the rat P2Y4
receptor is activated by both UTP and ATP as well as by ITP
(Bogdanov et al., 1998). As discussed above, an avian and a
xenopus P2Y receptor have been cloned that are potently
activated by all nucleoside triphosphates that have been tested.
Diculties in sampling the liquid layer immediately
surrounding the cell surface limit our understanding of the
potential autocrine roles of UTP and ATP. Basal levels of
UTP measured in the bulk medium of `non-stimulated'
cultured cells are below threshold values to promote P2Y2,
P2Y4 or P2Y6 receptor stimulation (Nicholas et al., 1996).
However, as suggested from recent studies, measurements of
nucleotide levels in bulk medium samples may underestimate
local accumulation, e.g., at cell surface receptors. Utilizing a
fusion system to anchor the ATP-speci®c enzyme luciferase to
the outer cell surface of human platelets, Dubyak and
colleagues observed that accumulation of ATP in the bulk
medium from thrombin-stimulated platelets underestimates
by at least one order of magnitude the ATP concentration in
the environment near the cell surface (Beigi et al., 1999).
Experiments with mechanically stimulated hP2Y4-1321N1
cells also suggested that local accumulation of UTP was
several fold higher than levels measured in the bulk medium
(Lazarowski et al., 1997a). Similarly, baseline accumulation
of inositol phosphates in resting hP2Y4-1321N1 cells
decreased signi®cantly after the addition of the non-speci®c
nucleotidase apyrase (Lazarowski et al., 1997a). Since ATP is
not an agonist at the human P2Y4 receptor, the most likely
explanation for these results is that under resting conditions,
UTP accumulates locally on the surface of 1321N1 cells in
amounts sucient to activate phospholipase C through the
P2Y4 receptor. Consistent with this notion, the baseline
[Ca2+] signal of non-stimulated hP2Y4-1321N1 cells was
markedly reduced upon inclusion of UDP-glucose pyropho-
sphorylase and glucose-1P in the bathing solution. (Homolya,
L. & Lazarowski, E.R., unpublished). `Constitutive' release of
UTP may provide a mechanism whereby the P2Y4 receptor,
and by analogy the P2Y2 and the P2Y6 receptors, regulate
`baseline functions' of resting cells.
In summary, the biological signi®cance of extracellular UTP
has been supported in recent years by pharmacological studies
of a series of G protein-coupled receptors that are potently
activated by UTP or UDP. The availability of an assay capable
of detecting UTP at low levels under a variety of conditions
should provide important methodology for linking the release
of cellular UTP to physiological responses through these
receptors in a variety of tissues.
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